Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Molecular Biology

Background:

• Osteoarthritis (OA) is a chronic joint disease involving inflammation and tissue degeneration.
• Extracellular vesicles (EVs) secreted by joint tissues play roles in OA pathogenesis.
• EVs contain bioactive molecules like microRNAs and proteins implicated in OA.

Purpose of the Study:

• To review OA-related biomarkers from EVs for diagnostic potential.
• To discuss the therapeutic applications of MSC-EVs and PRP-EVs for OA.
• To explore advanced strategies for EV-based OA diagnosis and therapy.

Main Methods:

• Literature review of recent studies on EVs in OA.
• Analysis of diagnostic potential using biosensors for EVs and biomarkers.
• Evaluation of therapeutic applications of MSC-EVs and PRP-EVs.
• Exploration of engineered EVs and biomaterial integration.

Main Results:

• OA tissue-derived EVs contain pathological biomarkers suitable for diagnostics.
• MSC-EVs and PRP-EVs demonstrate potential in suppressing inflammation and aiding cartilage repair.
• Current biosensor technology shows promise for EV detection.
• Engineered EVs and biomaterial composites offer enhanced therapeutic efficacy.

Conclusions:

• EVs hold significant potential for both diagnosing and treating osteoarthritis.
• Further research into engineered EVs and biomaterial integration can optimize OA therapies.
• EV-based approaches represent a promising future direction for OA management.